Annual Meeting Update: American College of Clinical Pharmacy

Biosimilars face challenges & type 2 diabetes drugs show cardiovascular & renal benefits Key takeaways from the American College of Clinical Pharmacy (ACCP) annual meeting in October 2019. Biosimilars I attended the ACCP meeting to present a poster on a case report involving an infliximab biosimilar, Renflexis, from when I was a post-graduate year one […]

Read More

Annual Meeting Update: Transcatheter Cardiovascular Therapeutics

4 highlights from the Cardiovascular Research Foundation’s annual symposium Key takeaways from the Transcatheter Cardiovascular Therapeutics (TCT) conference in September 2019. I attended the TCT educational conference for interventional cardiovascular medicine—a symposium held annually by the Cardiovascular Research Foundation (CRF) in September. Here are four of my primary takeaways from the conference:   1. Catheter-based […]

Read More

After a Warning, FDA OKs the Use of Paclitaxel-Coated Products

Update on an article published in the Q3 2019 edition of The Source. In January 2019, the Food and Drug Administration (FDA) sent out a warning letter to physicians and healthcare providers regarding a late-mortality safety signal with paclitaxel-coated balloons and stents, says Robin Cunningham, MSN, RN, former Director of Clinical Research at HealthTrust. In […]

Read More

Impacting the Waste Conundrum

Annual U.S. healthcare expenditures exceed $3.5 trillion. Healthcare sites and news feeds have been filled with commentary surrounding a study in the October 2019 edition of the Journal of the American Medical Association (JAMA). The study reports that waste accounts for roughly one-quarter of all U.S. healthcare spending across six domains developed by the Institute […]

Read More

The State of HAIs

Prevention & control of healthcare-associated infections Healthcare-associated infections (HAIs) are one of the most common adverse events in care delivery and a major public health problem with an impact on morbidity, mortality and quality of life. These infections also present a significant economic burden at the societal level. However, a large percentage of HAIs are […]

Read More

Ed Jones

Supporting Member Access to Essential Medicines

The market for generic injectables continues to be plagued by prolonged drug shortages on mission-critical medications. This serves to threaten patient safety and the ability of medical professionals to consistently provide quality care. In addition, healthcare providers are forced to manage unpredictable medication prices, creating unnecessary hurdles in delivering cost-effective therapy. In order to help […]

Read More

Platinum Reflections: From the Desk of Ed Jones

For two decades, HealthTrust has been at the forefront of supporting how quality healthcare is defined and delivered. Our committed model has stood the test of time and been an industry differentiator in modeling supply chain excellence and innovation. The milestones that have shaped HealthTrust over the last 20 years were presented through a visually […]

Read More